Bayesoft is an innovative early-stage startup revolutionizing drug development by integrating Bayesian statistics, advanced Bayesian clinical trial designs, and cutting-edge AI technologies. Dedicated to modernizing the pharmaceutical industry, Bayesoft delivers data-driven solutions that accelerate clinical development through adaptive decision-making, probabilistic modeling, and real-time evidence synthesis. Our platform supports contemporary Bayesian methodologies—including dose-finding, platform and basket designs, dynamic borrowing from external data sources, and event-driven interim analyses—to enable more efficient and informative trials.
Leveraging AI for intelligent decision support, Bayesoft empowers stakeholders across clinical R&D to evaluate competing strategies, quantify uncertainty, and optimize investment and execution decisions. A knowledge graph–powered drug development companion unifies scientific literature, trial registries, regulatory data, biomarkers, and mechanistic insights to form a continuously evolving map of therapeutic opportunity and risk—supporting faster insights, richer context, and stronger strategic alignment.
Situated at the forefront of technological advancement, Bayesoft fosters a collaborative and dynamic environment grounded in scientific rigor, practical impact, and translational innovation. With a strong commitment to reshaping how the biopharmaceutical industry discovers, designs, and develops new therapies, Bayesoft is helping define the future of evidence generation and drug development.

Bayesoft

Org chart

Teams

Offices